Lantikoagulantiaprofylax
Lantikoagulantiaprofylax refers to the prophylactic use of anticoagulant medications. This practice aims to prevent the formation of blood clots, also known as thrombosis, in individuals at increased risk. These medications work by interfering with the body's natural clotting process, thereby reducing the likelihood of a clot developing.
The decision to initiate lantikoagulantiaprofylax is based on a careful assessment of a patient's individual risk
Various classes of anticoagulant medications are available, including vitamin K antagonists (e.g., warfarin) and direct-acting oral